Viral Vaccines Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The Viral Vaccines Market size was valued at US$ 61.71 Billion in 2025 and is projected to reach US$ 91.88 Billion by 2033, growing at a CAGR of 5.1% during 2026–2033. Key drivers include immunization expansion, rising viral disease burden, adult vaccination uptake, and innovation in mRNA platforms, while opportunities stem from combination vaccines, emerging-market access, and strategic biomanufacturing investments.

Report Coverage

Form: Liquid, Lyophilized
Container Format: Vials, Prefilled Syringes
Biosafety Level Type: Biosafety Level 1, Biosafety Level 2, Biosafety Level 3, Biosafety Level 4

US$ 61.71 Bn Market size in 2025

US$ 91.88 Bn Market Size by 2033

5.10% CAGR, 2026 - 2033

2026-2033 Forecast Period

Download Sample PDF Buy Now

Format PDF + Excel + PPT

No. of Pages: 350

Category Life Sciences

Report Code: BMIPUB00038453

Last Updated: 2026-08-28

Author

Krishna Sunthwal

Analyst Connect

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Viral Vaccines Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Viral Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Viral Vaccines Market Global Analysis

6.2 Viral Vaccines Market Revenue 2022-2033 (US$ Billion)

6.3 Viral Vaccines Market Forecast Analysis

7. Viral Vaccines Market Analysis – by Form

7.1 Liquid

7.1.1 Overview
7.1.2 Liquid: Viral Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.2 Lyophilized

7.2.1 Overview
7.2.2 Lyophilized: Viral Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. Viral Vaccines Market Analysis – by Container Format

8.1 Vials

8.1.1 Overview
8.1.2 Vials: Viral Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.2 Prefilled Syringes

8.2.1 Overview
8.2.2 Prefilled Syringes: Viral Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. Viral Vaccines Market Analysis – by Biosafety Level Type

9.1 Biosafety Level 1

9.1.1 Overview
9.1.2 Biosafety Level 1: Viral Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.2 Biosafety Level 2

9.2.1 Overview
9.2.2 Biosafety Level 2: Viral Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.3 Biosafety Level 3

9.3.1 Overview
9.3.2 Biosafety Level 3: Viral Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.4 Biosafety Level 4

9.4.1 Overview
9.4.2 Biosafety Level 4: Viral Vaccines Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10. Viral Vaccines Market – Geographic Analysis

10.1 Overview

10.2 North America

10.2.1 Viral Vaccines Market Breakdown, by Key Country, 2026 and 2033 (%)
10.2.1.1 Viral Vaccines Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.2.1.1.1 US: Viral Vaccines Market Breakdown, by Form
10.2.1.1.2 US: Viral Vaccines Market Breakdown, by Container Format
10.2.1.1.3 US: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.2.1.2 Canada: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.2.1.2.1 Canada: Viral Vaccines Market Breakdown, by Form
10.2.1.2.2 Canada: Viral Vaccines Market Breakdown, by Container Format
10.2.1.2.3 Canada: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.2.1.3 Mexico: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.2.1.3.1 Mexico: Viral Vaccines Market Breakdown, by Form
10.2.1.3.2 Mexico: Viral Vaccines Market Breakdown, by Container Format
10.2.1.3.3 Mexico: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3 Europe

10.3.1 Viral Vaccines Market Breakdown, by Key Country, 2026 and 2033 (%)
10.3.1.1 Viral Vaccines Market – Revenue and Forecast Analysis – by Country
10.3.1.1 Germany: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.1.1 Germany: Viral Vaccines Market Breakdown, by Form
10.3.1.1.2 Germany: Viral Vaccines Market Breakdown, by Container Format
10.3.1.1.3 Germany: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.2 Italy: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.2.1 Italy: Viral Vaccines Market Breakdown, by Form
10.3.1.2.2 Italy: Viral Vaccines Market Breakdown, by Container Format
10.3.1.2.3 Italy: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.3 France: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.3.1 France: Viral Vaccines Market Breakdown, by Form
10.3.1.3.2 France: Viral Vaccines Market Breakdown, by Container Format
10.3.1.3.3 France: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.4 U.K.: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.4.1 U.K.: Viral Vaccines Market Breakdown, by Form
10.3.1.4.2 U.K.: Viral Vaccines Market Breakdown, by Container Format
10.3.1.4.3 U.K.: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.5 Spain: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.5.1 Spain: Viral Vaccines Market Breakdown, by Form
10.3.1.5.2 Spain: Viral Vaccines Market Breakdown, by Container Format
10.3.1.5.3 Spain: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.6 Belgium: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.6.1 Belgium: Viral Vaccines Market Breakdown, by Form
10.3.1.6.2 Belgium: Viral Vaccines Market Breakdown, by Container Format
10.3.1.6.3 Belgium: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.7 Netherlands: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.7.1 Netherlands: Viral Vaccines Market Breakdown, by Form
10.3.1.7.2 Netherlands: Viral Vaccines Market Breakdown, by Container Format
10.3.1.7.3 Netherlands: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.8 Luxembourg: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.8.1 Luxembourg: Viral Vaccines Market Breakdown, by Form
10.3.1.8.2 Luxembourg: Viral Vaccines Market Breakdown, by Container Format
10.3.1.8.3 Luxembourg: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.9 Norway: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.9.1 Norway: Viral Vaccines Market Breakdown, by Form
10.3.1.9.2 Norway: Viral Vaccines Market Breakdown, by Container Format
10.3.1.9.3 Norway: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.10 Finland: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.10.1 Finland: Viral Vaccines Market Breakdown, by Form
10.3.1.10.2 Finland: Viral Vaccines Market Breakdown, by Container Format
10.3.1.10.3 Finland: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.11 Denmark: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.11.1 Denmark: Viral Vaccines Market Breakdown, by Form
10.3.1.11.2 Denmark: Viral Vaccines Market Breakdown, by Container Format
10.3.1.11.3 Denmark: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.12 Sweden: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.12.1 Sweden: Viral Vaccines Market Breakdown, by Form
10.3.1.12.2 Sweden: Viral Vaccines Market Breakdown, by Container Format
10.3.1.12.3 Sweden: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.13 Switzerland: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.13.1 Switzerland: Viral Vaccines Market Breakdown, by Form
10.3.1.13.2 Switzerland: Viral Vaccines Market Breakdown, by Container Format
10.3.1.13.3 Switzerland: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.14 Austria: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.14.1 Austria: Viral Vaccines Market Breakdown, by Form
10.3.1.14.2 Austria: Viral Vaccines Market Breakdown, by Container Format
10.3.1.14.3 Austria: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.15 Greece: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.15.1 Greece: Viral Vaccines Market Breakdown, by Form
10.3.1.15.2 Greece: Viral Vaccines Market Breakdown, by Container Format
10.3.1.15.3 Greece: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.16 Portugal: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.16.1 Portugal: Viral Vaccines Market Breakdown, by Form
10.3.1.16.2 Portugal: Viral Vaccines Market Breakdown, by Container Format
10.3.1.16.3 Portugal: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.17 Russia: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.17.1 Russia: Viral Vaccines Market Breakdown, by Form
10.3.1.17.2 Russia: Viral Vaccines Market Breakdown, by Container Format
10.3.1.17.3 Russia: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.18 Poland: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.18.1 Poland: Viral Vaccines Market Breakdown, by Form
10.3.1.18.2 Poland: Viral Vaccines Market Breakdown, by Container Format
10.3.1.18.3 Poland: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.19 Romania: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.19.1 Romania: Viral Vaccines Market Breakdown, by Form
10.3.1.19.2 Romania: Viral Vaccines Market Breakdown, by Container Format
10.3.1.19.3 Romania: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.20 Czech Republic: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.20.1 Czech Republic: Viral Vaccines Market Breakdown, by Form
10.3.1.20.2 Czech Republic: Viral Vaccines Market Breakdown, by Container Format
10.3.1.20.3 Czech Republic: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.21 Ukraine: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.21.1 Ukraine: Viral Vaccines Market Breakdown, by Form
10.3.1.21.2 Ukraine: Viral Vaccines Market Breakdown, by Container Format
10.3.1.21.3 Ukraine: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.22 Slovakia: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.22.1 Slovakia: Viral Vaccines Market Breakdown, by Form
10.3.1.22.2 Slovakia: Viral Vaccines Market Breakdown, by Container Format
10.3.1.22.3 Slovakia: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.3.1.23 Bulgaria: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.3.1.23.1 Bulgaria: Viral Vaccines Market Breakdown, by Form
10.3.1.23.2 Bulgaria: Viral Vaccines Market Breakdown, by Container Format
10.3.1.23.3 Bulgaria: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4 Asia-Pacific

10.4.1 Viral Vaccines Market Breakdown, by Key Country, 2026 and 2033 (%)
10.4.1.1 Viral Vaccines Market – Revenue and Forecast Analysis – by Country
10.4.1.1 China: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.1.1 China: Viral Vaccines Market Breakdown, by Form
10.4.1.1.2 China: Viral Vaccines Market Breakdown, by Container Format
10.4.1.1.3 China: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.2 Japan: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.2.1 Japan: Viral Vaccines Market Breakdown, by Form
10.4.1.2.2 Japan: Viral Vaccines Market Breakdown, by Container Format
10.4.1.2.3 Japan: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.3 South Korea: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.3.1 South Korea: Viral Vaccines Market Breakdown, by Form
10.4.1.3.2 South Korea: Viral Vaccines Market Breakdown, by Container Format
10.4.1.3.3 South Korea: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.4 India: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.4.1 India: Viral Vaccines Market Breakdown, by Form
10.4.1.4.2 India: Viral Vaccines Market Breakdown, by Container Format
10.4.1.4.3 India: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.5 Australia: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.5.1 Australia: Viral Vaccines Market Breakdown, by Form
10.4.1.5.2 Australia: Viral Vaccines Market Breakdown, by Container Format
10.4.1.5.3 Australia: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.6 New Zealand: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.6.1 New Zealand: Viral Vaccines Market Breakdown, by Form
10.4.1.6.2 New Zealand: Viral Vaccines Market Breakdown, by Container Format
10.4.1.6.3 New Zealand: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.7 Indonesia: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.7.1 Indonesia: Viral Vaccines Market Breakdown, by Form
10.4.1.7.2 Indonesia: Viral Vaccines Market Breakdown, by Container Format
10.4.1.7.3 Indonesia: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.8 Malaysia: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.8.1 Malaysia: Viral Vaccines Market Breakdown, by Form
10.4.1.8.2 Malaysia: Viral Vaccines Market Breakdown, by Container Format
10.4.1.8.3 Malaysia: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.9 Philippines: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.9.1 Philippines: Viral Vaccines Market Breakdown, by Form
10.4.1.9.2 Philippines: Viral Vaccines Market Breakdown, by Container Format
10.4.1.9.3 Philippines: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.10 Singapore: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.10.1 Singapore: Viral Vaccines Market Breakdown, by Form
10.4.1.10.2 Singapore: Viral Vaccines Market Breakdown, by Container Format
10.4.1.10.3 Singapore: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.11 Thailand: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.11.1 Thailand: Viral Vaccines Market Breakdown, by Form
10.4.1.11.2 Thailand: Viral Vaccines Market Breakdown, by Container Format
10.4.1.11.3 Thailand: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.12 Vietnam: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.12.1 Vietnam: Viral Vaccines Market Breakdown, by Form
10.4.1.12.2 Vietnam: Viral Vaccines Market Breakdown, by Container Format
10.4.1.12.3 Vietnam: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.13 Taiwan: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.13.1 Taiwan: Viral Vaccines Market Breakdown, by Form
10.4.1.13.2 Taiwan: Viral Vaccines Market Breakdown, by Container Format
10.4.1.13.3 Taiwan: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.4.1.14 Bangladesh: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.4.1.14.1 Bangladesh: Viral Vaccines Market Breakdown, by Form
10.4.1.14.2 Bangladesh: Viral Vaccines Market Breakdown, by Container Format
10.4.1.14.3 Bangladesh: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.5 South and Central America

10.5.1 Viral Vaccines Market Breakdown, by Key Country, 2026 and 2033 (%)
10.5.1.1 Viral Vaccines Market – Revenue and Forecast Analysis – by Country
10.5.1.1 Brazil: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.1.1 Brazil: Viral Vaccines Market Breakdown, by Form
10.5.1.1.2 Brazil: Viral Vaccines Market Breakdown, by Container Format
10.5.1.1.3 Brazil: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.5.1.2 Argentina: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.2.1 Argentina: Viral Vaccines Market Breakdown, by Form
10.5.1.2.2 Argentina: Viral Vaccines Market Breakdown, by Container Format
10.5.1.2.3 Argentina: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.5.1.3 Chile: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.3.1 Chile: Viral Vaccines Market Breakdown, by Form
10.5.1.3.2 Chile: Viral Vaccines Market Breakdown, by Container Format
10.5.1.3.3 Chile: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.5.1.4 Colombia: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.4.1 Colombia: Viral Vaccines Market Breakdown, by Form
10.5.1.4.2 Colombia: Viral Vaccines Market Breakdown, by Container Format
10.5.1.4.3 Colombia: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.5.1.5 Peru: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.5.1.5.1 Peru: Viral Vaccines Market Breakdown, by Form
10.5.1.5.2 Peru: Viral Vaccines Market Breakdown, by Container Format
10.5.1.5.3 Peru: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.6 Middle East and Africa

10.6.1 Viral Vaccines Market Breakdown, by Key Country, 2026 and 2033 (%)
10.6.1.1 Viral Vaccines Market – Revenue and Forecast Analysis – by Country
10.6.1.1 Saudi Arabia: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.1.1 Saudi Arabia: Viral Vaccines Market Breakdown, by Form
10.6.1.1.2 Saudi Arabia: Viral Vaccines Market Breakdown, by Container Format
10.6.1.1.3 Saudi Arabia: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.6.1.2 United Arab Emirates: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.2.1 United Arab Emirates: Viral Vaccines Market Breakdown, by Form
10.6.1.2.2 United Arab Emirates: Viral Vaccines Market Breakdown, by Container Format
10.6.1.2.3 United Arab Emirates: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.6.1.3 Kuwait: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.3.1 Kuwait: Viral Vaccines Market Breakdown, by Form
10.6.1.3.2 Kuwait: Viral Vaccines Market Breakdown, by Container Format
10.6.1.3.3 Kuwait: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.6.1.4 Bahrain: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.4.1 Bahrain: Viral Vaccines Market Breakdown, by Form
10.6.1.4.2 Bahrain: Viral Vaccines Market Breakdown, by Container Format
10.6.1.4.3 Bahrain: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.6.1.5 Qatar: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.5.1 Qatar: Viral Vaccines Market Breakdown, by Form
10.6.1.5.2 Qatar: Viral Vaccines Market Breakdown, by Container Format
10.6.1.5.3 Qatar: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.6.1.6 Oman: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.6.1 Oman: Viral Vaccines Market Breakdown, by Form
10.6.1.6.2 Oman: Viral Vaccines Market Breakdown, by Container Format
10.6.1.6.3 Oman: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.6.1.7 Turkiye: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.7.1 Turkiye: Viral Vaccines Market Breakdown, by Form
10.6.1.7.2 Turkiye: Viral Vaccines Market Breakdown, by Container Format
10.6.1.7.3 Turkiye: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.6.1.8 South Africa: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.8.1 South Africa: Viral Vaccines Market Breakdown, by Form
10.6.1.8.2 South Africa: Viral Vaccines Market Breakdown, by Container Format
10.6.1.8.3 South Africa: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.6.1.9 Egypt: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.9.1 Egypt: Viral Vaccines Market Breakdown, by Form
10.6.1.9.2 Egypt: Viral Vaccines Market Breakdown, by Container Format
10.6.1.9.3 Egypt: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.6.1.10 Nigeria: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.10.1 Nigeria: Viral Vaccines Market Breakdown, by Form
10.6.1.10.2 Nigeria: Viral Vaccines Market Breakdown, by Container Format
10.6.1.10.3 Nigeria: Viral Vaccines Market Breakdown, by Biosafety Level Type

10.6.1.11 Algeria: Viral Vaccines Market – Revenue and Forecast to 2033 (US$ Billion)

10.6.1.11.1 Algeria: Viral Vaccines Market Breakdown, by Form
10.6.1.11.2 Algeria: Viral Vaccines Market Breakdown, by Container Format
10.6.1.11.3 Algeria: Viral Vaccines Market Breakdown, by Biosafety Level Type

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Pfizer Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Merck & Co., Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Sanofi

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 GSK plc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 AstraZeneca PLC

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 CSL Limited

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Serum Institute of India Pvt. Ltd.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Bavarian Nordic A/S

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Emergent BioSolutions Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Valneva SE.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Access the Full V Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization